Sinusitis and Hyperparathyroidism secondary

Summary:

Hyperparathyroidism secondary is found among people with Sinusitis, especially for people who are female, 60+ old.

The study analyzes which people have Hyperparathyroidism secondary with Sinusitis. It is created by eHealthMe based on reports of 13 people who have Sinusitis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Sinusitis?

Sinusitis (inflammation of sinus) is found to be associated with 2,400 drugs and 2,727 conditions by eHealthMe. Check the latest studies of Sinusitis.

What is Hyperparathyroidism secondary?

Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary) is found to be associated with 697 drugs and 461 conditions by eHealthMe. Check the latest studies of Hyperparathyroidism secondary.

On Aug, 08, 2026

13 people who have Sinusitis and Hyperparathyroidism Secondary are studied.

Would you have Hyperparathyroidism secondary when you have Sinusitis?

Gender of people who have Sinusitis and experienced Hyperparathyroidism Secondary *:

female: 76.92 %
male: 23.08 %

Age of people who have Sinusitis and experienced Hyperparathyroidism Secondary *:

Common co-existing conditions for these people *:

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 92.31%
High Blood Pressure: 10 people, 76.92%
Pain: 8 people, 61.54%
High Blood Cholesterol: 6 people, 46.15%
Infection: 6 people, 46.15%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 5 people, 38.46%
Depression: 5 people, 38.46%
Diabetes: 4 people, 30.77%
Anaemia (lack of blood): 4 people, 30.77%
Stress And Anxiety: 4 people, 30.77%

Common drugs taken by these people *:

Common symptoms for these people *:

Chronic Kidney Disease: 12 people, 92.31%
Acute Kidney Failure: 11 people, 84.62%
Nephrogenic Anaemia (anaemia due to kidney disease): 7 people, 53.85%
Renal Impairment (severely reduced kidney function): 2 people, 15.38%
Nephropathy (damage to or disease of a kidney): 2 people, 15.38%
Malignant Hypertension (a hypertensive emergency is a condition in which elevated blood pressure results in target organ damage): 1 person, 7.69%
Acute Phosphate Nephropathy (sudden damage to the kidneys caused by the formation of phosphate crystals): 1 person, 7.69%
Arteriovenous Fistula Site Complication: 1 person, 7.69%
Blood Creatinine Increased: 1 person, 7.69%
Dry Mouth: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hyperparathyroidism secondary?

- Check whether Hyperparathyroidism secondary is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hyperparathyroidism secondary and Sinusitis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.